Based on the evidence that the pro-inflammatory cytokine IL-1β promotes cancer cell aggressiveness and may favor EMT pathway activation [41,42], we conducted Western blot analysis to determine whether IL-1β stimulation modulates the fibronectin levels in TEVs (Figure 3). This evidence concerns the gene IL1B and cancer.